Global Nuclear Medicine PPE Market Growth 2026-2032
The global Nuclear Medicine PPE market size is predicted to grow from US$ 201 million in 2025 to US$ 277 million in 2032; it is expected to grow at a CAGR of 4.8% from 2026 to 2032.
In 2024, global Nuclear Medicine PPE production reached approximately 1353 k units , with an average global market price of around US$ 136 per unit. Nuclear medicine PPE is a general term for specialized equipment used to protect medical staff, technicians, patients, and related personnel from the hazards of radioactive radiation during nuclear medicine diagnosis and treatment. Its core function is to block or reduce human exposure to radioactive particles (such as alpha, beta, and gamma rays) through physical isolation, attenuation, and absorption. It encompasses a variety of specialized protective equipment, primarily protective clothing (such as lead vests, lead helmets, lead gloves, lead glasses, and lead aprons, made from lead or other high-density protective materials, with varying lead equivalents depending on the type and intensity of radiation), respiratory protection equipment, surface protection, and cleaning supplies.
In the global supply chain for nuclear medicine PPE, upstream raw material supply is crucial. Radiation-resistant materials, including lead and plexiglass, are at the core. Due to its high density, lead effectively shields gamma rays and is a common material in protective equipment. Lead suppliers (such as Doe Run in the United States and Nyrstar in Belgium) dominate the traditional protective clothing market. In the lead-free material market, companies like Mitsubishi Chemical in Japan and R?hm in Germany dominate the high-end market for PMMA. Their radiation-resistant modification technology directly determines the performance of beta-ray protective gear. Downstream nuclear medicine applications are diverse, encompassing nuclear medicine departments in hospitals, radiopharmaceutical research and development institutions, and nuclear medicine testing centers. In hospitals, medical staff must wear personal protective equipment (PPE) such as protective clothing, gloves, and glasses when handling radiopharmaceuticals and performing radionuclide imaging examinations to prevent radiation hazards. In R&D institutions, researchers work with various radioactive materials, placing even higher demands on the performance and comfort of their protective equipment. Testing centers also rely on high-quality PPE to ensure the safety of personnel during nuclear medicine testing projects. The demands of different scenarios are driving continuous innovation and improvement in protective equipment, prompting upstream and downstream companies to collaborate closely to optimize the supply chain and meet the growing protection needs in the global nuclear medicine field.
This Insight Report provides a comprehensive analysis of the global Nuclear Medicine PPE landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nuclear Medicine PPE portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nuclear Medicine PPE market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nuclear Medicine PPE and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nuclear Medicine PPE.
This report presents a comprehensive overview, market shares, and growth opportunities of Nuclear Medicine PPE market by product type, application, key manufacturers and key regions and countries.
In 2024, global Nuclear Medicine PPE production reached approximately 1353 k units , with an average global market price of around US$ 136 per unit. Nuclear medicine PPE is a general term for specialized equipment used to protect medical staff, technicians, patients, and related personnel from the hazards of radioactive radiation during nuclear medicine diagnosis and treatment. Its core function is to block or reduce human exposure to radioactive particles (such as alpha, beta, and gamma rays) through physical isolation, attenuation, and absorption. It encompasses a variety of specialized protective equipment, primarily protective clothing (such as lead vests, lead helmets, lead gloves, lead glasses, and lead aprons, made from lead or other high-density protective materials, with varying lead equivalents depending on the type and intensity of radiation), respiratory protection equipment, surface protection, and cleaning supplies.
In the global supply chain for nuclear medicine PPE, upstream raw material supply is crucial. Radiation-resistant materials, including lead and plexiglass, are at the core. Due to its high density, lead effectively shields gamma rays and is a common material in protective equipment. Lead suppliers (such as Doe Run in the United States and Nyrstar in Belgium) dominate the traditional protective clothing market. In the lead-free material market, companies like Mitsubishi Chemical in Japan and R?hm in Germany dominate the high-end market for PMMA. Their radiation-resistant modification technology directly determines the performance of beta-ray protective gear. Downstream nuclear medicine applications are diverse, encompassing nuclear medicine departments in hospitals, radiopharmaceutical research and development institutions, and nuclear medicine testing centers. In hospitals, medical staff must wear personal protective equipment (PPE) such as protective clothing, gloves, and glasses when handling radiopharmaceuticals and performing radionuclide imaging examinations to prevent radiation hazards. In R&D institutions, researchers work with various radioactive materials, placing even higher demands on the performance and comfort of their protective equipment. Testing centers also rely on high-quality PPE to ensure the safety of personnel during nuclear medicine testing projects. The demands of different scenarios are driving continuous innovation and improvement in protective equipment, prompting upstream and downstream companies to collaborate closely to optimize the supply chain and meet the growing protection needs in the global nuclear medicine field.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Nuclear Medicine PPE Industry Forecast” looks at past sales and reviews total world Nuclear Medicine PPE sales in 2025, providing a comprehensive analysis by region and market sector of projected Nuclear Medicine PPE sales for 2026 through 2032. With Nuclear Medicine PPE sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nuclear Medicine PPE industry.This Insight Report provides a comprehensive analysis of the global Nuclear Medicine PPE landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nuclear Medicine PPE portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nuclear Medicine PPE market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nuclear Medicine PPE and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nuclear Medicine PPE.
This report presents a comprehensive overview, market shares, and growth opportunities of Nuclear Medicine PPE market by product type, application, key manufacturers and key regions and countries.
Market Segmentation
Segmentation by Type:
- Gamma/X-Ray PPE
- Beta Ray PPE
- Neutron PPE
- Others
Segmentation by Material:
- Lead-containing PPE
- Lead-free PPE
Segmentation by Application:
- Radionuclide Imaging and Therapy
- Radiopharmaceutical Production and Packaging
- Nuclear Medicine Interventional Procedures
- Nuclear Medicine Laboratory Research
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- VF Nuclear
- Barrier Technologies
- Lemer Pax
- NuviaTech Healthcare
- Phillips Safety
- Protech Medical
- Raybloc
- Respirex International
- Ultraray
- Scanflex Medical
- Tema Sinergie
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Nuclear Medicine PPE market?
- What factors are driving Nuclear Medicine PPE market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Nuclear Medicine PPE market opportunities vary by end market size?
- How does Nuclear Medicine PPE break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nuclear Medicine PPE Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Nuclear Medicine PPE by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Nuclear Medicine PPE by Country/Region, 2021, 2025 & 2032
2.2 Nuclear Medicine PPE Segment by Type
2.2.1 Gamma/X-Ray PPE
2.2.2 Beta Ray PPE
2.2.3 Neutron PPE
2.2.4 Others
2.2.5 Nuclear Medicine PPE Sales by Type
2.2.5.1 Global Nuclear Medicine PPE Sales Market Share by Type (2021-2026)
2.2.5.2 Global Nuclear Medicine PPE Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Nuclear Medicine PPE Sale Price by Type (2021-2026)
2.3 Nuclear Medicine PPE Segment by Material
2.3.1 Lead-containing PPE
2.3.2 Lead-free PPE
2.3.3 Nuclear Medicine PPE Sales by Material
2.3.3.1 Global Nuclear Medicine PPE Sales Market Share by Material (2021-2026)
2.3.3.2 Global Nuclear Medicine PPE Revenue and Market Share by Material (2021-2026)
2.3.3.3 Global Nuclear Medicine PPE Sale Price by Material (2021-2026)
2.4 Nuclear Medicine PPE Segment by Application
2.4.1 Radionuclide Imaging and Therapy
2.4.2 Radiopharmaceutical Production and Packaging
2.4.3 Nuclear Medicine Interventional Procedures
2.4.4 Nuclear Medicine Laboratory Research
2.4.5 Others
2.4.6 Nuclear Medicine PPE Sales by Application
2.4.6.1 Global Nuclear Medicine PPE Sale Market Share by Application (2021-2026)
2.4.6.2 Global Nuclear Medicine PPE Revenue and Market Share by Application (2021-2026)
2.4.6.3 Global Nuclear Medicine PPE Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Nuclear Medicine PPE Breakdown Data by Company
3.1.1 Global Nuclear Medicine PPE Annual Sales by Company (2021-2026)
3.1.2 Global Nuclear Medicine PPE Sales Market Share by Company (2021-2026)
3.2 Global Nuclear Medicine PPE Annual Revenue by Company (2021-2026)
3.2.1 Global Nuclear Medicine PPE Revenue by Company (2021-2026)
3.2.2 Global Nuclear Medicine PPE Revenue Market Share by Company (2021-2026)
3.3 Global Nuclear Medicine PPE Sale Price by Company
3.4 Key Manufacturers Nuclear Medicine PPE Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nuclear Medicine PPE Product Location Distribution
3.4.2 Players Nuclear Medicine PPE Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NUCLEAR MEDICINE PPE BY GEOGRAPHIC REGION
4.1 World Historic Nuclear Medicine PPE Market Size by Geographic Region (2021-2026)
4.1.1 Global Nuclear Medicine PPE Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Nuclear Medicine PPE Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Nuclear Medicine PPE Market Size by Country/Region (2021-2026)
4.2.1 Global Nuclear Medicine PPE Annual Sales by Country/Region (2021-2026)
4.2.2 Global Nuclear Medicine PPE Annual Revenue by Country/Region (2021-2026)
4.3 Americas Nuclear Medicine PPE Sales Growth
4.4 APAC Nuclear Medicine PPE Sales Growth
4.5 Europe Nuclear Medicine PPE Sales Growth
4.6 Middle East & Africa Nuclear Medicine PPE Sales Growth
5 AMERICAS
5.1 Americas Nuclear Medicine PPE Sales by Country
5.1.1 Americas Nuclear Medicine PPE Sales by Country (2021-2026)
5.1.2 Americas Nuclear Medicine PPE Revenue by Country (2021-2026)
5.2 Americas Nuclear Medicine PPE Sales by Type (2021-2026)
5.3 Americas Nuclear Medicine PPE Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nuclear Medicine PPE Sales by Region
6.1.1 APAC Nuclear Medicine PPE Sales by Region (2021-2026)
6.1.2 APAC Nuclear Medicine PPE Revenue by Region (2021-2026)
6.2 APAC Nuclear Medicine PPE Sales by Type (2021-2026)
6.3 APAC Nuclear Medicine PPE Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Nuclear Medicine PPE by Country
7.1.1 Europe Nuclear Medicine PPE Sales by Country (2021-2026)
7.1.2 Europe Nuclear Medicine PPE Revenue by Country (2021-2026)
7.2 Europe Nuclear Medicine PPE Sales by Type (2021-2026)
7.3 Europe Nuclear Medicine PPE Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nuclear Medicine PPE by Country
8.1.1 Middle East & Africa Nuclear Medicine PPE Sales by Country (2021-2026)
8.1.2 Middle East & Africa Nuclear Medicine PPE Revenue by Country (2021-2026)
8.2 Middle East & Africa Nuclear Medicine PPE Sales by Type (2021-2026)
8.3 Middle East & Africa Nuclear Medicine PPE Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nuclear Medicine PPE
10.3 Manufacturing Process Analysis of Nuclear Medicine PPE
10.4 Industry Chain Structure of Nuclear Medicine PPE
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nuclear Medicine PPE Distributors
11.3 Nuclear Medicine PPE Customer
12 WORLD FORECAST REVIEW FOR NUCLEAR MEDICINE PPE BY GEOGRAPHIC REGION
12.1 Global Nuclear Medicine PPE Market Size Forecast by Region
12.1.1 Global Nuclear Medicine PPE Forecast by Region (2027-2032)
12.1.2 Global Nuclear Medicine PPE Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Nuclear Medicine PPE Forecast by Type (2027-2032)
12.7 Global Nuclear Medicine PPE Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 VF Nuclear
13.1.1 VF Nuclear Company Information
13.1.2 VF Nuclear Nuclear Medicine PPE Product Portfolios and Specifications
13.1.3 VF Nuclear Nuclear Medicine PPE Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 VF Nuclear Main Business Overview
13.1.5 VF Nuclear Latest Developments
13.2 Barrier Technologies
13.2.1 Barrier Technologies Company Information
13.2.2 Barrier Technologies Nuclear Medicine PPE Product Portfolios and Specifications
13.2.3 Barrier Technologies Nuclear Medicine PPE Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Barrier Technologies Main Business Overview
13.2.5 Barrier Technologies Latest Developments
13.3 Lemer Pax
13.3.1 Lemer Pax Company Information
13.3.2 Lemer Pax Nuclear Medicine PPE Product Portfolios and Specifications
13.3.3 Lemer Pax Nuclear Medicine PPE Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Lemer Pax Main Business Overview
13.3.5 Lemer Pax Latest Developments
13.4 NuviaTech Healthcare
13.4.1 NuviaTech Healthcare Company Information
13.4.2 NuviaTech Healthcare Nuclear Medicine PPE Product Portfolios and Specifications
13.4.3 NuviaTech Healthcare Nuclear Medicine PPE Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 NuviaTech Healthcare Main Business Overview
13.4.5 NuviaTech Healthcare Latest Developments
13.5 Phillips Safety
13.5.1 Phillips Safety Company Information
13.5.2 Phillips Safety Nuclear Medicine PPE Product Portfolios and Specifications
13.5.3 Phillips Safety Nuclear Medicine PPE Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Phillips Safety Main Business Overview
13.5.5 Phillips Safety Latest Developments
13.6 Protech Medical
13.6.1 Protech Medical Company Information
13.6.2 Protech Medical Nuclear Medicine PPE Product Portfolios and Specifications
13.6.3 Protech Medical Nuclear Medicine PPE Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Protech Medical Main Business Overview
13.6.5 Protech Medical Latest Developments
13.7 Raybloc
13.7.1 Raybloc Company Information
13.7.2 Raybloc Nuclear Medicine PPE Product Portfolios and Specifications
13.7.3 Raybloc Nuclear Medicine PPE Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Raybloc Main Business Overview
13.7.5 Raybloc Latest Developments
13.8 Respirex International
13.8.1 Respirex International Company Information
13.8.2 Respirex International Nuclear Medicine PPE Product Portfolios and Specifications
13.8.3 Respirex International Nuclear Medicine PPE Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Respirex International Main Business Overview
13.8.5 Respirex International Latest Developments
13.9 Ultraray
13.9.1 Ultraray Company Information
13.9.2 Ultraray Nuclear Medicine PPE Product Portfolios and Specifications
13.9.3 Ultraray Nuclear Medicine PPE Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Ultraray Main Business Overview
13.9.5 Ultraray Latest Developments
13.10 Scanflex Medical
13.10.1 Scanflex Medical Company Information
13.10.2 Scanflex Medical Nuclear Medicine PPE Product Portfolios and Specifications
13.10.3 Scanflex Medical Nuclear Medicine PPE Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Scanflex Medical Main Business Overview
13.10.5 Scanflex Medical Latest Developments
13.11 Tema Sinergie
13.11.1 Tema Sinergie Company Information
13.11.2 Tema Sinergie Nuclear Medicine PPE Product Portfolios and Specifications
13.11.3 Tema Sinergie Nuclear Medicine PPE Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Tema Sinergie Main Business Overview
13.11.5 Tema Sinergie Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nuclear Medicine PPE Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Nuclear Medicine PPE by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Nuclear Medicine PPE by Country/Region, 2021, 2025 & 2032
2.2 Nuclear Medicine PPE Segment by Type
2.2.1 Gamma/X-Ray PPE
2.2.2 Beta Ray PPE
2.2.3 Neutron PPE
2.2.4 Others
2.2.5 Nuclear Medicine PPE Sales by Type
2.2.5.1 Global Nuclear Medicine PPE Sales Market Share by Type (2021-2026)
2.2.5.2 Global Nuclear Medicine PPE Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Nuclear Medicine PPE Sale Price by Type (2021-2026)
2.3 Nuclear Medicine PPE Segment by Material
2.3.1 Lead-containing PPE
2.3.2 Lead-free PPE
2.3.3 Nuclear Medicine PPE Sales by Material
2.3.3.1 Global Nuclear Medicine PPE Sales Market Share by Material (2021-2026)
2.3.3.2 Global Nuclear Medicine PPE Revenue and Market Share by Material (2021-2026)
2.3.3.3 Global Nuclear Medicine PPE Sale Price by Material (2021-2026)
2.4 Nuclear Medicine PPE Segment by Application
2.4.1 Radionuclide Imaging and Therapy
2.4.2 Radiopharmaceutical Production and Packaging
2.4.3 Nuclear Medicine Interventional Procedures
2.4.4 Nuclear Medicine Laboratory Research
2.4.5 Others
2.4.6 Nuclear Medicine PPE Sales by Application
2.4.6.1 Global Nuclear Medicine PPE Sale Market Share by Application (2021-2026)
2.4.6.2 Global Nuclear Medicine PPE Revenue and Market Share by Application (2021-2026)
2.4.6.3 Global Nuclear Medicine PPE Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Nuclear Medicine PPE Breakdown Data by Company
3.1.1 Global Nuclear Medicine PPE Annual Sales by Company (2021-2026)
3.1.2 Global Nuclear Medicine PPE Sales Market Share by Company (2021-2026)
3.2 Global Nuclear Medicine PPE Annual Revenue by Company (2021-2026)
3.2.1 Global Nuclear Medicine PPE Revenue by Company (2021-2026)
3.2.2 Global Nuclear Medicine PPE Revenue Market Share by Company (2021-2026)
3.3 Global Nuclear Medicine PPE Sale Price by Company
3.4 Key Manufacturers Nuclear Medicine PPE Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nuclear Medicine PPE Product Location Distribution
3.4.2 Players Nuclear Medicine PPE Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NUCLEAR MEDICINE PPE BY GEOGRAPHIC REGION
4.1 World Historic Nuclear Medicine PPE Market Size by Geographic Region (2021-2026)
4.1.1 Global Nuclear Medicine PPE Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Nuclear Medicine PPE Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Nuclear Medicine PPE Market Size by Country/Region (2021-2026)
4.2.1 Global Nuclear Medicine PPE Annual Sales by Country/Region (2021-2026)
4.2.2 Global Nuclear Medicine PPE Annual Revenue by Country/Region (2021-2026)
4.3 Americas Nuclear Medicine PPE Sales Growth
4.4 APAC Nuclear Medicine PPE Sales Growth
4.5 Europe Nuclear Medicine PPE Sales Growth
4.6 Middle East & Africa Nuclear Medicine PPE Sales Growth
5 AMERICAS
5.1 Americas Nuclear Medicine PPE Sales by Country
5.1.1 Americas Nuclear Medicine PPE Sales by Country (2021-2026)
5.1.2 Americas Nuclear Medicine PPE Revenue by Country (2021-2026)
5.2 Americas Nuclear Medicine PPE Sales by Type (2021-2026)
5.3 Americas Nuclear Medicine PPE Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nuclear Medicine PPE Sales by Region
6.1.1 APAC Nuclear Medicine PPE Sales by Region (2021-2026)
6.1.2 APAC Nuclear Medicine PPE Revenue by Region (2021-2026)
6.2 APAC Nuclear Medicine PPE Sales by Type (2021-2026)
6.3 APAC Nuclear Medicine PPE Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Nuclear Medicine PPE by Country
7.1.1 Europe Nuclear Medicine PPE Sales by Country (2021-2026)
7.1.2 Europe Nuclear Medicine PPE Revenue by Country (2021-2026)
7.2 Europe Nuclear Medicine PPE Sales by Type (2021-2026)
7.3 Europe Nuclear Medicine PPE Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nuclear Medicine PPE by Country
8.1.1 Middle East & Africa Nuclear Medicine PPE Sales by Country (2021-2026)
8.1.2 Middle East & Africa Nuclear Medicine PPE Revenue by Country (2021-2026)
8.2 Middle East & Africa Nuclear Medicine PPE Sales by Type (2021-2026)
8.3 Middle East & Africa Nuclear Medicine PPE Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nuclear Medicine PPE
10.3 Manufacturing Process Analysis of Nuclear Medicine PPE
10.4 Industry Chain Structure of Nuclear Medicine PPE
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nuclear Medicine PPE Distributors
11.3 Nuclear Medicine PPE Customer
12 WORLD FORECAST REVIEW FOR NUCLEAR MEDICINE PPE BY GEOGRAPHIC REGION
12.1 Global Nuclear Medicine PPE Market Size Forecast by Region
12.1.1 Global Nuclear Medicine PPE Forecast by Region (2027-2032)
12.1.2 Global Nuclear Medicine PPE Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Nuclear Medicine PPE Forecast by Type (2027-2032)
12.7 Global Nuclear Medicine PPE Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 VF Nuclear
13.1.1 VF Nuclear Company Information
13.1.2 VF Nuclear Nuclear Medicine PPE Product Portfolios and Specifications
13.1.3 VF Nuclear Nuclear Medicine PPE Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 VF Nuclear Main Business Overview
13.1.5 VF Nuclear Latest Developments
13.2 Barrier Technologies
13.2.1 Barrier Technologies Company Information
13.2.2 Barrier Technologies Nuclear Medicine PPE Product Portfolios and Specifications
13.2.3 Barrier Technologies Nuclear Medicine PPE Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Barrier Technologies Main Business Overview
13.2.5 Barrier Technologies Latest Developments
13.3 Lemer Pax
13.3.1 Lemer Pax Company Information
13.3.2 Lemer Pax Nuclear Medicine PPE Product Portfolios and Specifications
13.3.3 Lemer Pax Nuclear Medicine PPE Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Lemer Pax Main Business Overview
13.3.5 Lemer Pax Latest Developments
13.4 NuviaTech Healthcare
13.4.1 NuviaTech Healthcare Company Information
13.4.2 NuviaTech Healthcare Nuclear Medicine PPE Product Portfolios and Specifications
13.4.3 NuviaTech Healthcare Nuclear Medicine PPE Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 NuviaTech Healthcare Main Business Overview
13.4.5 NuviaTech Healthcare Latest Developments
13.5 Phillips Safety
13.5.1 Phillips Safety Company Information
13.5.2 Phillips Safety Nuclear Medicine PPE Product Portfolios and Specifications
13.5.3 Phillips Safety Nuclear Medicine PPE Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Phillips Safety Main Business Overview
13.5.5 Phillips Safety Latest Developments
13.6 Protech Medical
13.6.1 Protech Medical Company Information
13.6.2 Protech Medical Nuclear Medicine PPE Product Portfolios and Specifications
13.6.3 Protech Medical Nuclear Medicine PPE Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Protech Medical Main Business Overview
13.6.5 Protech Medical Latest Developments
13.7 Raybloc
13.7.1 Raybloc Company Information
13.7.2 Raybloc Nuclear Medicine PPE Product Portfolios and Specifications
13.7.3 Raybloc Nuclear Medicine PPE Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Raybloc Main Business Overview
13.7.5 Raybloc Latest Developments
13.8 Respirex International
13.8.1 Respirex International Company Information
13.8.2 Respirex International Nuclear Medicine PPE Product Portfolios and Specifications
13.8.3 Respirex International Nuclear Medicine PPE Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Respirex International Main Business Overview
13.8.5 Respirex International Latest Developments
13.9 Ultraray
13.9.1 Ultraray Company Information
13.9.2 Ultraray Nuclear Medicine PPE Product Portfolios and Specifications
13.9.3 Ultraray Nuclear Medicine PPE Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Ultraray Main Business Overview
13.9.5 Ultraray Latest Developments
13.10 Scanflex Medical
13.10.1 Scanflex Medical Company Information
13.10.2 Scanflex Medical Nuclear Medicine PPE Product Portfolios and Specifications
13.10.3 Scanflex Medical Nuclear Medicine PPE Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Scanflex Medical Main Business Overview
13.10.5 Scanflex Medical Latest Developments
13.11 Tema Sinergie
13.11.1 Tema Sinergie Company Information
13.11.2 Tema Sinergie Nuclear Medicine PPE Product Portfolios and Specifications
13.11.3 Tema Sinergie Nuclear Medicine PPE Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Tema Sinergie Main Business Overview
13.11.5 Tema Sinergie Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Nuclear Medicine PPE Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Nuclear Medicine PPE Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Gamma/X-Ray PPE
Table 4. Major Players of Beta Ray PPE
Table 5. Major Players of Neutron PPE
Table 6. Major Players of Others
Table 7. Global Nuclear Medicine PPE Sales by Type (2021-2026) & (K Units)
Table 8. Global Nuclear Medicine PPE Sales Market Share by Type (2021-2026)
Table 9. Global Nuclear Medicine PPE Revenue by Type (2021-2026) & ($ million)
Table 10. Global Nuclear Medicine PPE Revenue Market Share by Type (2021-2026)
Table 11. Global Nuclear Medicine PPE Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Major Players of Lead-containing PPE
Table 13. Major Players of Lead-free PPE
Table 14. Global Nuclear Medicine PPE Sales by Material (2021-2026) & (K Units)
Table 15. Global Nuclear Medicine PPE Sales Market Share by Material (2021-2026)
Table 16. Global Nuclear Medicine PPE Revenue by Material (2021-2026) & ($ million)
Table 17. Global Nuclear Medicine PPE Revenue Market Share by Material (2021-2026)
Table 18. Global Nuclear Medicine PPE Sale Price by Material (2021-2026) & (US$/Unit)
Table 19. Global Nuclear Medicine PPE Sale by Application (2021-2026) & (K Units)
Table 20. Global Nuclear Medicine PPE Sale Market Share by Application (2021-2026)
Table 21. Global Nuclear Medicine PPE Revenue by Application (2021-2026) & ($ million)
Table 22. Global Nuclear Medicine PPE Revenue Market Share by Application (2021-2026)
Table 23. Global Nuclear Medicine PPE Sale Price by Application (2021-2026) & (US$/Unit)
Table 24. Global Nuclear Medicine PPE Sales by Company (2021-2026) & (K Units)
Table 25. Global Nuclear Medicine PPE Sales Market Share by Company (2021-2026)
Table 26. Global Nuclear Medicine PPE Revenue by Company (2021-2026) & ($ millions)
Table 27. Global Nuclear Medicine PPE Revenue Market Share by Company (2021-2026)
Table 28. Global Nuclear Medicine PPE Sale Price by Company (2021-2026) & (US$/Unit)
Table 29. Key Manufacturers Nuclear Medicine PPE Producing Area Distribution and Sales Area
Table 30. Players Nuclear Medicine PPE Products Offered
Table 31. Nuclear Medicine PPE Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 32. New Products and Potential Entrants
Table 33. Market M&A Activity & Strategy
Table 34. Global Nuclear Medicine PPE Sales by Geographic Region (2021-2026) & (K Units)
Table 35. Global Nuclear Medicine PPE Sales Market Share Geographic Region (2021-2026)
Table 36. Global Nuclear Medicine PPE Revenue by Geographic Region (2021-2026) & ($ millions)
Table 37. Global Nuclear Medicine PPE Revenue Market Share by Geographic Region (2021-2026)
Table 38. Global Nuclear Medicine PPE Sales by Country/Region (2021-2026) & (K Units)
Table 39. Global Nuclear Medicine PPE Sales Market Share by Country/Region (2021-2026)
Table 40. Global Nuclear Medicine PPE Revenue by Country/Region (2021-2026) & ($ millions)
Table 41. Global Nuclear Medicine PPE Revenue Market Share by Country/Region (2021-2026)
Table 42. Americas Nuclear Medicine PPE Sales by Country (2021-2026) & (K Units)
Table 43. Americas Nuclear Medicine PPE Sales Market Share by Country (2021-2026)
Table 44. Americas Nuclear Medicine PPE Revenue by Country (2021-2026) & ($ millions)
Table 45. Americas Nuclear Medicine PPE Sales by Type (2021-2026) & (K Units)
Table 46. Americas Nuclear Medicine PPE Sales by Application (2021-2026) & (K Units)
Table 47. APAC Nuclear Medicine PPE Sales by Region (2021-2026) & (K Units)
Table 48. APAC Nuclear Medicine PPE Sales Market Share by Region (2021-2026)
Table 49. APAC Nuclear Medicine PPE Revenue by Region (2021-2026) & ($ millions)
Table 50. APAC Nuclear Medicine PPE Sales by Type (2021-2026) & (K Units)
Table 51. APAC Nuclear Medicine PPE Sales by Application (2021-2026) & (K Units)
Table 52. Europe Nuclear Medicine PPE Sales by Country (2021-2026) & (K Units)
Table 53. Europe Nuclear Medicine PPE Revenue by Country (2021-2026) & ($ millions)
Table 54. Europe Nuclear Medicine PPE Sales by Type (2021-2026) & (K Units)
Table 55. Europe Nuclear Medicine PPE Sales by Application (2021-2026) & (K Units)
Table 56. Middle East & Africa Nuclear Medicine PPE Sales by Country (2021-2026) & (K Units)
Table 57. Middle East & Africa Nuclear Medicine PPE Revenue Market Share by Country (2021-2026)
Table 58. Middle East & Africa Nuclear Medicine PPE Sales by Type (2021-2026) & (K Units)
Table 59. Middle East & Africa Nuclear Medicine PPE Sales by Application (2021-2026) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Nuclear Medicine PPE
Table 61. Key Market Challenges & Risks of Nuclear Medicine PPE
Table 62. Key Industry Trends of Nuclear Medicine PPE
Table 63. Nuclear Medicine PPE Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Nuclear Medicine PPE Distributors List
Table 66. Nuclear Medicine PPE Customer List
Table 67. Global Nuclear Medicine PPE Sales Forecast by Region (2027-2032) & (K Units)
Table 68. Global Nuclear Medicine PPE Revenue Forecast by Region (2027-2032) & ($ millions)
Table 69. Americas Nuclear Medicine PPE Sales Forecast by Country (2027-2032) & (K Units)
Table 70. Americas Nuclear Medicine PPE Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. APAC Nuclear Medicine PPE Sales Forecast by Region (2027-2032) & (K Units)
Table 72. APAC Nuclear Medicine PPE Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 73. Europe Nuclear Medicine PPE Sales Forecast by Country (2027-2032) & (K Units)
Table 74. Europe Nuclear Medicine PPE Revenue Forecast by Country (2027-2032) & ($ millions)
Table 75. Middle East & Africa Nuclear Medicine PPE Sales Forecast by Country (2027-2032) & (K Units)
Table 76. Middle East & Africa Nuclear Medicine PPE Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. Global Nuclear Medicine PPE Sales Forecast by Type (2027-2032) & (K Units)
Table 78. Global Nuclear Medicine PPE Revenue Forecast by Type (2027-2032) & ($ millions)
Table 79. Global Nuclear Medicine PPE Sales Forecast by Application (2027-2032) & (K Units)
Table 80. Global Nuclear Medicine PPE Revenue Forecast by Application (2027-2032) & ($ millions)
Table 81. VF Nuclear Basic Information, Nuclear Medicine PPE Manufacturing Base, Sales Area and Its Competitors
Table 82. VF Nuclear Nuclear Medicine PPE Product Portfolios and Specifications
Table 83. VF Nuclear Nuclear Medicine PPE Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 84. VF Nuclear Main Business
Table 85. VF Nuclear Latest Developments
Table 86. Barrier Technologies Basic Information, Nuclear Medicine PPE Manufacturing Base, Sales Area and Its Competitors
Table 87. Barrier Technologies Nuclear Medicine PPE Product Portfolios and Specifications
Table 88. Barrier Technologies Nuclear Medicine PPE Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. Barrier Technologies Main Business
Table 90. Barrier Technologies Latest Developments
Table 91. Lemer Pax Basic Information, Nuclear Medicine PPE Manufacturing Base, Sales Area and Its Competitors
Table 92. Lemer Pax Nuclear Medicine PPE Product Portfolios and Specifications
Table 93. Lemer Pax Nuclear Medicine PPE Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 94. Lemer Pax Main Business
Table 95. Lemer Pax Latest Developments
Table 96. NuviaTech Healthcare Basic Information, Nuclear Medicine PPE Manufacturing Base, Sales Area and Its Competitors
Table 97. NuviaTech Healthcare Nuclear Medicine PPE Product Portfolios and Specifications
Table 98. NuviaTech Healthcare Nuclear Medicine PPE Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 99. NuviaTech Healthcare Main Business
Table 100. NuviaTech Healthcare Latest Developments
Table 101. Phillips Safety Basic Information, Nuclear Medicine PPE Manufacturing Base, Sales Area and Its Competitors
Table 102. Phillips Safety Nuclear Medicine PPE Product Portfolios and Specifications
Table 103. Phillips Safety Nuclear Medicine PPE Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 104. Phillips Safety Main Business
Table 105. Phillips Safety Latest Developments
Table 106. Protech Medical Basic Information, Nuclear Medicine PPE Manufacturing Base, Sales Area and Its Competitors
Table 107. Protech Medical Nuclear Medicine PPE Product Portfolios and Specifications
Table 108. Protech Medical Nuclear Medicine PPE Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 109. Protech Medical Main Business
Table 110. Protech Medical Latest Developments
Table 111. Raybloc Basic Information, Nuclear Medicine PPE Manufacturing Base, Sales Area and Its Competitors
Table 112. Raybloc Nuclear Medicine PPE Product Portfolios and Specifications
Table 113. Raybloc Nuclear Medicine PPE Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 114. Raybloc Main Business
Table 115. Raybloc Latest Developments
Table 116. Respirex International Basic Information, Nuclear Medicine PPE Manufacturing Base, Sales Area and Its Competitors
Table 117. Respirex International Nuclear Medicine PPE Product Portfolios and Specifications
Table 118. Respirex International Nuclear Medicine PPE Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 119. Respirex International Main Business
Table 120. Respirex International Latest Developments
Table 121. Ultraray Basic Information, Nuclear Medicine PPE Manufacturing Base, Sales Area and Its Competitors
Table 122. Ultraray Nuclear Medicine PPE Product Portfolios and Specifications
Table 123. Ultraray Nuclear Medicine PPE Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 124. Ultraray Main Business
Table 125. Ultraray Latest Developments
Table 126. Scanflex Medical Basic Information, Nuclear Medicine PPE Manufacturing Base, Sales Area and Its Competitors
Table 127. Scanflex Medical Nuclear Medicine PPE Product Portfolios and Specifications
Table 128. Scanflex Medical Nuclear Medicine PPE Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 129. Scanflex Medical Main Business
Table 130. Scanflex Medical Latest Developments
Table 131. Tema Sinergie Basic Information, Nuclear Medicine PPE Manufacturing Base, Sales Area and Its Competitors
Table 132. Tema Sinergie Nuclear Medicine PPE Product Portfolios and Specifications
Table 133. Tema Sinergie Nuclear Medicine PPE Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 134. Tema Sinergie Main Business
Table 135. Tema Sinergie Latest Developments
Table 1. Nuclear Medicine PPE Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Nuclear Medicine PPE Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Gamma/X-Ray PPE
Table 4. Major Players of Beta Ray PPE
Table 5. Major Players of Neutron PPE
Table 6. Major Players of Others
Table 7. Global Nuclear Medicine PPE Sales by Type (2021-2026) & (K Units)
Table 8. Global Nuclear Medicine PPE Sales Market Share by Type (2021-2026)
Table 9. Global Nuclear Medicine PPE Revenue by Type (2021-2026) & ($ million)
Table 10. Global Nuclear Medicine PPE Revenue Market Share by Type (2021-2026)
Table 11. Global Nuclear Medicine PPE Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Major Players of Lead-containing PPE
Table 13. Major Players of Lead-free PPE
Table 14. Global Nuclear Medicine PPE Sales by Material (2021-2026) & (K Units)
Table 15. Global Nuclear Medicine PPE Sales Market Share by Material (2021-2026)
Table 16. Global Nuclear Medicine PPE Revenue by Material (2021-2026) & ($ million)
Table 17. Global Nuclear Medicine PPE Revenue Market Share by Material (2021-2026)
Table 18. Global Nuclear Medicine PPE Sale Price by Material (2021-2026) & (US$/Unit)
Table 19. Global Nuclear Medicine PPE Sale by Application (2021-2026) & (K Units)
Table 20. Global Nuclear Medicine PPE Sale Market Share by Application (2021-2026)
Table 21. Global Nuclear Medicine PPE Revenue by Application (2021-2026) & ($ million)
Table 22. Global Nuclear Medicine PPE Revenue Market Share by Application (2021-2026)
Table 23. Global Nuclear Medicine PPE Sale Price by Application (2021-2026) & (US$/Unit)
Table 24. Global Nuclear Medicine PPE Sales by Company (2021-2026) & (K Units)
Table 25. Global Nuclear Medicine PPE Sales Market Share by Company (2021-2026)
Table 26. Global Nuclear Medicine PPE Revenue by Company (2021-2026) & ($ millions)
Table 27. Global Nuclear Medicine PPE Revenue Market Share by Company (2021-2026)
Table 28. Global Nuclear Medicine PPE Sale Price by Company (2021-2026) & (US$/Unit)
Table 29. Key Manufacturers Nuclear Medicine PPE Producing Area Distribution and Sales Area
Table 30. Players Nuclear Medicine PPE Products Offered
Table 31. Nuclear Medicine PPE Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 32. New Products and Potential Entrants
Table 33. Market M&A Activity & Strategy
Table 34. Global Nuclear Medicine PPE Sales by Geographic Region (2021-2026) & (K Units)
Table 35. Global Nuclear Medicine PPE Sales Market Share Geographic Region (2021-2026)
Table 36. Global Nuclear Medicine PPE Revenue by Geographic Region (2021-2026) & ($ millions)
Table 37. Global Nuclear Medicine PPE Revenue Market Share by Geographic Region (2021-2026)
Table 38. Global Nuclear Medicine PPE Sales by Country/Region (2021-2026) & (K Units)
Table 39. Global Nuclear Medicine PPE Sales Market Share by Country/Region (2021-2026)
Table 40. Global Nuclear Medicine PPE Revenue by Country/Region (2021-2026) & ($ millions)
Table 41. Global Nuclear Medicine PPE Revenue Market Share by Country/Region (2021-2026)
Table 42. Americas Nuclear Medicine PPE Sales by Country (2021-2026) & (K Units)
Table 43. Americas Nuclear Medicine PPE Sales Market Share by Country (2021-2026)
Table 44. Americas Nuclear Medicine PPE Revenue by Country (2021-2026) & ($ millions)
Table 45. Americas Nuclear Medicine PPE Sales by Type (2021-2026) & (K Units)
Table 46. Americas Nuclear Medicine PPE Sales by Application (2021-2026) & (K Units)
Table 47. APAC Nuclear Medicine PPE Sales by Region (2021-2026) & (K Units)
Table 48. APAC Nuclear Medicine PPE Sales Market Share by Region (2021-2026)
Table 49. APAC Nuclear Medicine PPE Revenue by Region (2021-2026) & ($ millions)
Table 50. APAC Nuclear Medicine PPE Sales by Type (2021-2026) & (K Units)
Table 51. APAC Nuclear Medicine PPE Sales by Application (2021-2026) & (K Units)
Table 52. Europe Nuclear Medicine PPE Sales by Country (2021-2026) & (K Units)
Table 53. Europe Nuclear Medicine PPE Revenue by Country (2021-2026) & ($ millions)
Table 54. Europe Nuclear Medicine PPE Sales by Type (2021-2026) & (K Units)
Table 55. Europe Nuclear Medicine PPE Sales by Application (2021-2026) & (K Units)
Table 56. Middle East & Africa Nuclear Medicine PPE Sales by Country (2021-2026) & (K Units)
Table 57. Middle East & Africa Nuclear Medicine PPE Revenue Market Share by Country (2021-2026)
Table 58. Middle East & Africa Nuclear Medicine PPE Sales by Type (2021-2026) & (K Units)
Table 59. Middle East & Africa Nuclear Medicine PPE Sales by Application (2021-2026) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Nuclear Medicine PPE
Table 61. Key Market Challenges & Risks of Nuclear Medicine PPE
Table 62. Key Industry Trends of Nuclear Medicine PPE
Table 63. Nuclear Medicine PPE Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Nuclear Medicine PPE Distributors List
Table 66. Nuclear Medicine PPE Customer List
Table 67. Global Nuclear Medicine PPE Sales Forecast by Region (2027-2032) & (K Units)
Table 68. Global Nuclear Medicine PPE Revenue Forecast by Region (2027-2032) & ($ millions)
Table 69. Americas Nuclear Medicine PPE Sales Forecast by Country (2027-2032) & (K Units)
Table 70. Americas Nuclear Medicine PPE Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. APAC Nuclear Medicine PPE Sales Forecast by Region (2027-2032) & (K Units)
Table 72. APAC Nuclear Medicine PPE Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 73. Europe Nuclear Medicine PPE Sales Forecast by Country (2027-2032) & (K Units)
Table 74. Europe Nuclear Medicine PPE Revenue Forecast by Country (2027-2032) & ($ millions)
Table 75. Middle East & Africa Nuclear Medicine PPE Sales Forecast by Country (2027-2032) & (K Units)
Table 76. Middle East & Africa Nuclear Medicine PPE Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. Global Nuclear Medicine PPE Sales Forecast by Type (2027-2032) & (K Units)
Table 78. Global Nuclear Medicine PPE Revenue Forecast by Type (2027-2032) & ($ millions)
Table 79. Global Nuclear Medicine PPE Sales Forecast by Application (2027-2032) & (K Units)
Table 80. Global Nuclear Medicine PPE Revenue Forecast by Application (2027-2032) & ($ millions)
Table 81. VF Nuclear Basic Information, Nuclear Medicine PPE Manufacturing Base, Sales Area and Its Competitors
Table 82. VF Nuclear Nuclear Medicine PPE Product Portfolios and Specifications
Table 83. VF Nuclear Nuclear Medicine PPE Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 84. VF Nuclear Main Business
Table 85. VF Nuclear Latest Developments
Table 86. Barrier Technologies Basic Information, Nuclear Medicine PPE Manufacturing Base, Sales Area and Its Competitors
Table 87. Barrier Technologies Nuclear Medicine PPE Product Portfolios and Specifications
Table 88. Barrier Technologies Nuclear Medicine PPE Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. Barrier Technologies Main Business
Table 90. Barrier Technologies Latest Developments
Table 91. Lemer Pax Basic Information, Nuclear Medicine PPE Manufacturing Base, Sales Area and Its Competitors
Table 92. Lemer Pax Nuclear Medicine PPE Product Portfolios and Specifications
Table 93. Lemer Pax Nuclear Medicine PPE Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 94. Lemer Pax Main Business
Table 95. Lemer Pax Latest Developments
Table 96. NuviaTech Healthcare Basic Information, Nuclear Medicine PPE Manufacturing Base, Sales Area and Its Competitors
Table 97. NuviaTech Healthcare Nuclear Medicine PPE Product Portfolios and Specifications
Table 98. NuviaTech Healthcare Nuclear Medicine PPE Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 99. NuviaTech Healthcare Main Business
Table 100. NuviaTech Healthcare Latest Developments
Table 101. Phillips Safety Basic Information, Nuclear Medicine PPE Manufacturing Base, Sales Area and Its Competitors
Table 102. Phillips Safety Nuclear Medicine PPE Product Portfolios and Specifications
Table 103. Phillips Safety Nuclear Medicine PPE Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 104. Phillips Safety Main Business
Table 105. Phillips Safety Latest Developments
Table 106. Protech Medical Basic Information, Nuclear Medicine PPE Manufacturing Base, Sales Area and Its Competitors
Table 107. Protech Medical Nuclear Medicine PPE Product Portfolios and Specifications
Table 108. Protech Medical Nuclear Medicine PPE Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 109. Protech Medical Main Business
Table 110. Protech Medical Latest Developments
Table 111. Raybloc Basic Information, Nuclear Medicine PPE Manufacturing Base, Sales Area and Its Competitors
Table 112. Raybloc Nuclear Medicine PPE Product Portfolios and Specifications
Table 113. Raybloc Nuclear Medicine PPE Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 114. Raybloc Main Business
Table 115. Raybloc Latest Developments
Table 116. Respirex International Basic Information, Nuclear Medicine PPE Manufacturing Base, Sales Area and Its Competitors
Table 117. Respirex International Nuclear Medicine PPE Product Portfolios and Specifications
Table 118. Respirex International Nuclear Medicine PPE Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 119. Respirex International Main Business
Table 120. Respirex International Latest Developments
Table 121. Ultraray Basic Information, Nuclear Medicine PPE Manufacturing Base, Sales Area and Its Competitors
Table 122. Ultraray Nuclear Medicine PPE Product Portfolios and Specifications
Table 123. Ultraray Nuclear Medicine PPE Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 124. Ultraray Main Business
Table 125. Ultraray Latest Developments
Table 126. Scanflex Medical Basic Information, Nuclear Medicine PPE Manufacturing Base, Sales Area and Its Competitors
Table 127. Scanflex Medical Nuclear Medicine PPE Product Portfolios and Specifications
Table 128. Scanflex Medical Nuclear Medicine PPE Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 129. Scanflex Medical Main Business
Table 130. Scanflex Medical Latest Developments
Table 131. Tema Sinergie Basic Information, Nuclear Medicine PPE Manufacturing Base, Sales Area and Its Competitors
Table 132. Tema Sinergie Nuclear Medicine PPE Product Portfolios and Specifications
Table 133. Tema Sinergie Nuclear Medicine PPE Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 134. Tema Sinergie Main Business
Table 135. Tema Sinergie Latest Developments
LIST OF FIGURES
Figure 1. Picture of Nuclear Medicine PPE
Figure 2. Nuclear Medicine PPE Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nuclear Medicine PPE Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Nuclear Medicine PPE Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Nuclear Medicine PPE Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Nuclear Medicine PPE Sales Market Share by Country/Region (2025)
Figure 10. Nuclear Medicine PPE Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Gamma/X-Ray PPE
Figure 12. Product Picture of Beta Ray PPE
Figure 13. Product Picture of Neutron PPE
Figure 14. Product Picture of Others
Figure 15. Global Nuclear Medicine PPE Sales Market Share by Type in 2026
Figure 16. Global Nuclear Medicine PPE Revenue Market Share by Type (2021-2026)
Figure 17. Product Picture of Lead-containing PPE
Figure 18. Product Picture of Lead-free PPE
Figure 19. Global Nuclear Medicine PPE Sales Market Share by Material in 2026
Figure 20. Global Nuclear Medicine PPE Revenue Market Share by Material (2021-2026)
Figure 21. Nuclear Medicine PPE Consumed in Radionuclide Imaging and Therapy
Figure 22. Global Nuclear Medicine PPE Market: Radionuclide Imaging and Therapy (2021-2026) & (K Units)
Figure 23. Nuclear Medicine PPE Consumed in Radiopharmaceutical Production and Packaging
Figure 24. Global Nuclear Medicine PPE Market: Radiopharmaceutical Production and Packaging (2021-2026) & (K Units)
Figure 25. Nuclear Medicine PPE Consumed in Nuclear Medicine Interventional Procedures
Figure 26. Global Nuclear Medicine PPE Market: Nuclear Medicine Interventional Procedures (2021-2026) & (K Units)
Figure 27. Nuclear Medicine PPE Consumed in Nuclear Medicine Laboratory Research
Figure 28. Global Nuclear Medicine PPE Market: Nuclear Medicine Laboratory Research (2021-2026) & (K Units)
Figure 29. Nuclear Medicine PPE Consumed in Others
Figure 30. Global Nuclear Medicine PPE Market: Others (2021-2026) & (K Units)
Figure 31. Global Nuclear Medicine PPE Sale Market Share by Application (2025)
Figure 32. Global Nuclear Medicine PPE Revenue Market Share by Application in 2026
Figure 33. Nuclear Medicine PPE Sales by Company in 2026 (K Units)
Figure 34. Global Nuclear Medicine PPE Sales Market Share by Company in 2026
Figure 35. Nuclear Medicine PPE Revenue by Company in 2026 ($ millions)
Figure 36. Global Nuclear Medicine PPE Revenue Market Share by Company in 2026
Figure 37. Global Nuclear Medicine PPE Sales Market Share by Geographic Region (2021-2026)
Figure 38. Global Nuclear Medicine PPE Revenue Market Share by Geographic Region in 2026
Figure 39. Americas Nuclear Medicine PPE Sales 2021-2026 (K Units)
Figure 40. Americas Nuclear Medicine PPE Revenue 2021-2026 ($ millions)
Figure 41. APAC Nuclear Medicine PPE Sales 2021-2026 (K Units)
Figure 42. APAC Nuclear Medicine PPE Revenue 2021-2026 ($ millions)
Figure 43. Europe Nuclear Medicine PPE Sales 2021-2026 (K Units)
Figure 44. Europe Nuclear Medicine PPE Revenue 2021-2026 ($ millions)
Figure 45. Middle East & Africa Nuclear Medicine PPE Sales 2021-2026 (K Units)
Figure 46. Middle East & Africa Nuclear Medicine PPE Revenue 2021-2026 ($ millions)
Figure 47. Americas Nuclear Medicine PPE Sales Market Share by Country in 2026
Figure 48. Americas Nuclear Medicine PPE Revenue Market Share by Country (2021-2026)
Figure 49. Americas Nuclear Medicine PPE Sales Market Share by Type (2021-2026)
Figure 50. Americas Nuclear Medicine PPE Sales Market Share by Application (2021-2026)
Figure 51. United States Nuclear Medicine PPE Revenue Growth 2021-2026 ($ millions)
Figure 52. Canada Nuclear Medicine PPE Revenue Growth 2021-2026 ($ millions)
Figure 53. Mexico Nuclear Medicine PPE Revenue Growth 2021-2026 ($ millions)
Figure 54. Brazil Nuclear Medicine PPE Revenue Growth 2021-2026 ($ millions)
Figure 55. APAC Nuclear Medicine PPE Sales Market Share by Region in 2026
Figure 56. APAC Nuclear Medicine PPE Revenue Market Share by Region (2021-2026)
Figure 57. APAC Nuclear Medicine PPE Sales Market Share by Type (2021-2026)
Figure 58. APAC Nuclear Medicine PPE Sales Market Share by Application (2021-2026)
Figure 59. China Nuclear Medicine PPE Revenue Growth 2021-2026 ($ millions)
Figure 60. Japan Nuclear Medicine PPE Revenue Growth 2021-2026 ($ millions)
Figure 61. South Korea Nuclear Medicine PPE Revenue Growth 2021-2026 ($ millions)
Figure 62. Southeast Asia Nuclear Medicine PPE Revenue Growth 2021-2026 ($ millions)
Figure 63. India Nuclear Medicine PPE Revenue Growth 2021-2026 ($ millions)
Figure 64. Australia Nuclear Medicine PPE Revenue Growth 2021-2026 ($ millions)
Figure 65. China Taiwan Nuclear Medicine PPE Revenue Growth 2021-2026 ($ millions)
Figure 66. Europe Nuclear Medicine PPE Sales Market Share by Country in 2026
Figure 67. Europe Nuclear Medicine PPE Revenue Market Share by Country (2021-2026)
Figure 68. Europe Nuclear Medicine PPE Sales Market Share by Type (2021-2026)
Figure 69. Europe Nuclear Medicine PPE Sales Market Share by Application (2021-2026)
Figure 70. Germany Nuclear Medicine PPE Revenue Growth 2021-2026 ($ millions)
Figure 71. France Nuclear Medicine PPE Revenue Growth 2021-2026 ($ millions)
Figure 72. UK Nuclear Medicine PPE Revenue Growth 2021-2026 ($ millions)
Figure 73. Italy Nuclear Medicine PPE Revenue Growth 2021-2026 ($ millions)
Figure 74. Russia Nuclear Medicine PPE Revenue Growth 2021-2026 ($ millions)
Figure 75. Middle East & Africa Nuclear Medicine PPE Sales Market Share by Country (2021-2026)
Figure 76. Middle East & Africa Nuclear Medicine PPE Sales Market Share by Type (2021-2026)
Figure 77. Middle East & Africa Nuclear Medicine PPE Sales Market Share by Application (2021-2026)
Figure 78. Egypt Nuclear Medicine PPE Revenue Growth 2021-2026 ($ millions)
Figure 79. South Africa Nuclear Medicine PPE Revenue Growth 2021-2026 ($ millions)
Figure 80. Israel Nuclear Medicine PPE Revenue Growth 2021-2026 ($ millions)
Figure 81. Turkey Nuclear Medicine PPE Revenue Growth 2021-2026 ($ millions)
Figure 82. GCC Countries Nuclear Medicine PPE Revenue Growth 2021-2026 ($ millions)
Figure 83. Manufacturing Cost Structure Analysis of Nuclear Medicine PPE in 2026
Figure 84. Manufacturing Process Analysis of Nuclear Medicine PPE
Figure 85. Industry Chain Structure of Nuclear Medicine PPE
Figure 86. Channels of Distribution
Figure 87. Global Nuclear Medicine PPE Sales Market Forecast by Region (2027-2032)
Figure 88. Global Nuclear Medicine PPE Revenue Market Share Forecast by Region (2027-2032)
Figure 89. Global Nuclear Medicine PPE Sales Market Share Forecast by Type (2027-2032)
Figure 90. Global Nuclear Medicine PPE Revenue Market Share Forecast by Type (2027-2032)
Figure 91. Global Nuclear Medicine PPE Sales Market Share Forecast by Application (2027-2032)
Figure 92. Global Nuclear Medicine PPE Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Nuclear Medicine PPE
Figure 2. Nuclear Medicine PPE Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nuclear Medicine PPE Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Nuclear Medicine PPE Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Nuclear Medicine PPE Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Nuclear Medicine PPE Sales Market Share by Country/Region (2025)
Figure 10. Nuclear Medicine PPE Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Gamma/X-Ray PPE
Figure 12. Product Picture of Beta Ray PPE
Figure 13. Product Picture of Neutron PPE
Figure 14. Product Picture of Others
Figure 15. Global Nuclear Medicine PPE Sales Market Share by Type in 2026
Figure 16. Global Nuclear Medicine PPE Revenue Market Share by Type (2021-2026)
Figure 17. Product Picture of Lead-containing PPE
Figure 18. Product Picture of Lead-free PPE
Figure 19. Global Nuclear Medicine PPE Sales Market Share by Material in 2026
Figure 20. Global Nuclear Medicine PPE Revenue Market Share by Material (2021-2026)
Figure 21. Nuclear Medicine PPE Consumed in Radionuclide Imaging and Therapy
Figure 22. Global Nuclear Medicine PPE Market: Radionuclide Imaging and Therapy (2021-2026) & (K Units)
Figure 23. Nuclear Medicine PPE Consumed in Radiopharmaceutical Production and Packaging
Figure 24. Global Nuclear Medicine PPE Market: Radiopharmaceutical Production and Packaging (2021-2026) & (K Units)
Figure 25. Nuclear Medicine PPE Consumed in Nuclear Medicine Interventional Procedures
Figure 26. Global Nuclear Medicine PPE Market: Nuclear Medicine Interventional Procedures (2021-2026) & (K Units)
Figure 27. Nuclear Medicine PPE Consumed in Nuclear Medicine Laboratory Research
Figure 28. Global Nuclear Medicine PPE Market: Nuclear Medicine Laboratory Research (2021-2026) & (K Units)
Figure 29. Nuclear Medicine PPE Consumed in Others
Figure 30. Global Nuclear Medicine PPE Market: Others (2021-2026) & (K Units)
Figure 31. Global Nuclear Medicine PPE Sale Market Share by Application (2025)
Figure 32. Global Nuclear Medicine PPE Revenue Market Share by Application in 2026
Figure 33. Nuclear Medicine PPE Sales by Company in 2026 (K Units)
Figure 34. Global Nuclear Medicine PPE Sales Market Share by Company in 2026
Figure 35. Nuclear Medicine PPE Revenue by Company in 2026 ($ millions)
Figure 36. Global Nuclear Medicine PPE Revenue Market Share by Company in 2026
Figure 37. Global Nuclear Medicine PPE Sales Market Share by Geographic Region (2021-2026)
Figure 38. Global Nuclear Medicine PPE Revenue Market Share by Geographic Region in 2026
Figure 39. Americas Nuclear Medicine PPE Sales 2021-2026 (K Units)
Figure 40. Americas Nuclear Medicine PPE Revenue 2021-2026 ($ millions)
Figure 41. APAC Nuclear Medicine PPE Sales 2021-2026 (K Units)
Figure 42. APAC Nuclear Medicine PPE Revenue 2021-2026 ($ millions)
Figure 43. Europe Nuclear Medicine PPE Sales 2021-2026 (K Units)
Figure 44. Europe Nuclear Medicine PPE Revenue 2021-2026 ($ millions)
Figure 45. Middle East & Africa Nuclear Medicine PPE Sales 2021-2026 (K Units)
Figure 46. Middle East & Africa Nuclear Medicine PPE Revenue 2021-2026 ($ millions)
Figure 47. Americas Nuclear Medicine PPE Sales Market Share by Country in 2026
Figure 48. Americas Nuclear Medicine PPE Revenue Market Share by Country (2021-2026)
Figure 49. Americas Nuclear Medicine PPE Sales Market Share by Type (2021-2026)
Figure 50. Americas Nuclear Medicine PPE Sales Market Share by Application (2021-2026)
Figure 51. United States Nuclear Medicine PPE Revenue Growth 2021-2026 ($ millions)
Figure 52. Canada Nuclear Medicine PPE Revenue Growth 2021-2026 ($ millions)
Figure 53. Mexico Nuclear Medicine PPE Revenue Growth 2021-2026 ($ millions)
Figure 54. Brazil Nuclear Medicine PPE Revenue Growth 2021-2026 ($ millions)
Figure 55. APAC Nuclear Medicine PPE Sales Market Share by Region in 2026
Figure 56. APAC Nuclear Medicine PPE Revenue Market Share by Region (2021-2026)
Figure 57. APAC Nuclear Medicine PPE Sales Market Share by Type (2021-2026)
Figure 58. APAC Nuclear Medicine PPE Sales Market Share by Application (2021-2026)
Figure 59. China Nuclear Medicine PPE Revenue Growth 2021-2026 ($ millions)
Figure 60. Japan Nuclear Medicine PPE Revenue Growth 2021-2026 ($ millions)
Figure 61. South Korea Nuclear Medicine PPE Revenue Growth 2021-2026 ($ millions)
Figure 62. Southeast Asia Nuclear Medicine PPE Revenue Growth 2021-2026 ($ millions)
Figure 63. India Nuclear Medicine PPE Revenue Growth 2021-2026 ($ millions)
Figure 64. Australia Nuclear Medicine PPE Revenue Growth 2021-2026 ($ millions)
Figure 65. China Taiwan Nuclear Medicine PPE Revenue Growth 2021-2026 ($ millions)
Figure 66. Europe Nuclear Medicine PPE Sales Market Share by Country in 2026
Figure 67. Europe Nuclear Medicine PPE Revenue Market Share by Country (2021-2026)
Figure 68. Europe Nuclear Medicine PPE Sales Market Share by Type (2021-2026)
Figure 69. Europe Nuclear Medicine PPE Sales Market Share by Application (2021-2026)
Figure 70. Germany Nuclear Medicine PPE Revenue Growth 2021-2026 ($ millions)
Figure 71. France Nuclear Medicine PPE Revenue Growth 2021-2026 ($ millions)
Figure 72. UK Nuclear Medicine PPE Revenue Growth 2021-2026 ($ millions)
Figure 73. Italy Nuclear Medicine PPE Revenue Growth 2021-2026 ($ millions)
Figure 74. Russia Nuclear Medicine PPE Revenue Growth 2021-2026 ($ millions)
Figure 75. Middle East & Africa Nuclear Medicine PPE Sales Market Share by Country (2021-2026)
Figure 76. Middle East & Africa Nuclear Medicine PPE Sales Market Share by Type (2021-2026)
Figure 77. Middle East & Africa Nuclear Medicine PPE Sales Market Share by Application (2021-2026)
Figure 78. Egypt Nuclear Medicine PPE Revenue Growth 2021-2026 ($ millions)
Figure 79. South Africa Nuclear Medicine PPE Revenue Growth 2021-2026 ($ millions)
Figure 80. Israel Nuclear Medicine PPE Revenue Growth 2021-2026 ($ millions)
Figure 81. Turkey Nuclear Medicine PPE Revenue Growth 2021-2026 ($ millions)
Figure 82. GCC Countries Nuclear Medicine PPE Revenue Growth 2021-2026 ($ millions)
Figure 83. Manufacturing Cost Structure Analysis of Nuclear Medicine PPE in 2026
Figure 84. Manufacturing Process Analysis of Nuclear Medicine PPE
Figure 85. Industry Chain Structure of Nuclear Medicine PPE
Figure 86. Channels of Distribution
Figure 87. Global Nuclear Medicine PPE Sales Market Forecast by Region (2027-2032)
Figure 88. Global Nuclear Medicine PPE Revenue Market Share Forecast by Region (2027-2032)
Figure 89. Global Nuclear Medicine PPE Sales Market Share Forecast by Type (2027-2032)
Figure 90. Global Nuclear Medicine PPE Revenue Market Share Forecast by Type (2027-2032)
Figure 91. Global Nuclear Medicine PPE Sales Market Share Forecast by Application (2027-2032)
Figure 92. Global Nuclear Medicine PPE Revenue Market Share Forecast by Application (2027-2032)
